Economic impact of individualized antimicrobial dose optimization in the critically ill patient in Spain
In critically ill patients undergoing antimicrobial therapy TDM, there is an increased likelihood of cure. However, the currently available data are not conclusive on the economic impact of such a therapeutic effect.
Authors
- Carlos Rubio-Terrés (ORCID: https://orcid.org/0000-0001-5106-2912)
- Santiago Grau (ORCID: https://orcid.org/0000-0002-8428-1836)
- Sònia Luque (ORCID: https://orcid.org/0000-0002-3215-320X)
- Darío Rubio-Rodríguez
- A Cano
- Olivia Ferrández
Institutions
- Universitat Pompeu Fabra (ES)
- Madrid Health Service (ES)
- Parc de Salut (ES)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fphar.2025.1506109
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Instituto de Salud Carlos III